[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370498-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370498-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unraveling-the-nexus-genomic-instability-and-metabolism-in-cancer","Unraveling the nexus - Genomic instability and metabolism in cancer","","The DNA-damage response (DDR) is presented as a signaling network that detects and repairs genomic injury, while DDR inhibition has emerged as an effective cancer treatment approach. Yet tumor cells frequently evade these therapies through energetic metabolic reprogramming and altered redox control, creating exploitable redox vulnerabilities. The review synthesizes current findings on DDR–metabolism crosstalk, describes combination strategies targeting DDR, metabolism, and redox weaknesses, and discusses practical barriers and potential solutions for metabolic targeting.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unraveling-the-nexus-genomic-instability-and-metabolism-in-cancer/370498/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unraveling-the-nexus-genomic-instability-and-metabolism-in-cancer/370498.png","ImageObject",300,407,{"name":42,"@type":43},"\tCallum ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the DNA-damage response (DDR) and why is it important in cancer therapy?","Question",{"text":63,"@type":64},"DDR is a signaling network that enables cells to detect and repair genomic damage. Inhibiting DDR has been shown to be an effective cancer therapeutic strategy, though tumors often develop resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do metabolic reprogramming and redox changes undermine DDR-targeted treatments?",{"text":68,"@type":64},"Tumor cells can rewire energetic metabolism in response to DDR inhibition, including impaired redox metabolism. Metabolic intermediates also affect how tumors sense oxidative stress and activate cell-death pathways, producing redox vulnerabilities that can also drive resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"What combination approaches does the review propose for targeting DDR and metabolism in cancer?",{"text":72,"@type":64},"The review summarizes combination therapies that target DDR together with metabolism and redox vulnerabilities. It also outlines obstacles in targeting metabolism and proposes strategies to address these challenges.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370498,1790217334,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Cell Rep. Author manuscript; available in PMC 2025 April 30. |\n| --- | --- |\n\nPublished in final edited form as:  \nCell Rep. 2025 April 22; 44(4): 115540. doi:10.1016/j.celrep.2025.115540 .  \nUnraveling the nexus: Genomic instability and metabolism in cancer  \nVaibhavi Gujar1,4 , Haojian Li 1,4 , Tanya T. Paull2 , Carola A. Neumann3 , Urbain Weyemi 1,*  \n1 NCI Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA  \n2 Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA  \n3 Department of Pharmacology and Chemical Biology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA  \n4These authors contributed equally  \nSUMMARY  \nThe DNA-damage response (DDR) is a signaling network that enables cells to detect and repair genomic damage. Over the past three decades, inhibiting DDR has proven to be an effective cancer therapeutic strategy. Although cancer drugs targeting DDR have received approval for treating various cancers, tumor cells often develop resistance to these therapies, owing to their ability to undergo energetic metabolic reprogramming. Metabolic intermediates also influence tumor cells’ ability to sense oxidative stress, leading to impaired redox metabolism, thus creating redox vulnerabilities. In this review, we summarize recent advances in understanding the crosstalk between DDR and metabolism. We discuss combination therapies that target DDR, metabolism, and redox vulnerabilities in cancer. We also outline potential obstacles in targeting metabolism and propose strategies to overcome these challenges.  \nINTRODUCTION  \nGenomic instability and altered metabolism are two well-established hallmarks of cancer cells.1 Genomic instability consists of a characteristic of cells with a genome susceptible to mutations or any other forms of DNA damage. Cells with genomic instability are often prone to genetic alterations such as mutations in single genes, gene duplications, gene amplifications, deletions, or insertions. These genetic alterations constitute a major  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n*[Correspondence: urbain.weyemi@nih.gov](Correspondence: urbain.weyemi@nih.gov).  \nAUTHOR CONTRIBUTIONS  \nV.G., H.L., T.T.P., C.A.N., and U.W. conceived of the manuscript. V.G., H.L., T.T.P., C.A.N., and U.W. reviewed the literature, drafted the manuscript, and drew the figures. U.W. supervised and revised the manuscript. All authors read and approved the final manuscript.  \nDECLARATION OF INTERESTS  \nThe authors declare no competing interests.  \nDECLARATION OF GENERATIVE AI AND AI-ASSISTED TECHNOLOGIES IN THE WRITING PROCESS  \nDuring the preparation of this manuscript, the lead author used Chatbot for Intramural Research Program (ChIRP) in a few sections in order to improve readability for a broad audience. After using this tool, the author reviewed and edited the content as needed and takes full responsibility for the content of the publication.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nGujar et al. Page 2  \ncancer hallmark prompting for the development of cancer therapies that target DNA-damage response. As such, metabolism and genomic instability are closely linked to tumorigenesis and cancer progression, since cellular pathways essential for genome repair and normal cell proliferation heavily rely on many metabolic intermediates.2–4 These metabolic intermediates serve as temporary products in the cascade of biochemical reactions that drive metabolic pathways in living organisms. These molecules are essential for cellular function, growth, and fate. They can be found in most pathways of central carbon metabolism, including gly","cbCait2Eh4Fp6bqw","https://ap.wps.com/l/cbCait2Eh4Fp6bqw","pdf",1122364,29,"English","# Summary\n# Introduction\n# DDR, metabolism, and redox crosstalk\n## Metabolic intermediates and oxidative stress sensing\n## Redox vulnerabilities and cell-death pathways\n# Targeting genomic instability via DDR inhibition\n## Therapeutic rationale and precision medicine\n## Limitations from metabolic pathway rewiring\n# Combination therapies and translational challenges","[{\"question\":\"What is the DNA-damage response (DDR) and why is it important in cancer therapy?\",\"answer\":\"DDR is a signaling network that enables cells to detect and repair genomic damage. Inhibiting DDR has been shown to be an effective cancer therapeutic strategy, though tumors often develop resistance.\"},{\"question\":\"How do metabolic reprogramming and redox changes undermine DDR-targeted treatments?\",\"answer\":\"Tumor cells can rewire energetic metabolism in response to DDR inhibition, including impaired redox metabolism. Metabolic intermediates also affect how tumors sense oxidative stress and activate cell-death pathways, producing redox vulnerabilities that can also drive resistance.\"},{\"question\":\"What combination approaches does the review propose for targeting DDR and metabolism in cancer?\",\"answer\":\"The review summarizes combination therapies that target DDR together with metabolism and redox vulnerabilities. It also outlines obstacles in targeting metabolism and proposes strategies to address these challenges.\"}]","Unraveling the nexus - Genomic instability and metabolism in cancer | PDF",1790188832,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2a81832f9349cefeecc68f2260c0573.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb2c02b7aa64b591d705fcf04900f48f.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18d565358abbadf5efe0cffb74b5043e.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b18d8a5d76ececaf851ed5b382fce71f.webp",980,1268]